| 2025-11-07 | +28.1% | earnings | Seeking Alpha | SANUWAVE targets $13M–$14M Q4 revenue while leveraging post-CMS rule clarity |
| 2025-11-07 | +28.1% | earnings | Seeking Alpha | SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript |
| 2025-11-07 | +28.1% | earnings | Seeking Alpha | SANUWAVE Health GAAP EPS of $0.46 beats by $0.14, revenue of $11.5M beats by $0.07M |
| 2025-11-07 | +28.1% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2025-08-08 | +24.0% | earnings | Seeking Alpha | SANUWAVE outlines Q3 revenue target of $12M–$12.7M as new applicator production nears launch |
| 2025-08-08 | +24.0% | earnings | Seeking Alpha | SANUWAVE Health, Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-08-08 | +24.0% | earnings | Seeking Alpha | SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript |
| 2025-08-08 | +24.0% | earnings | Seeking Alpha | SANUWAVE Health GAAP EPS of $0.01 beats by $0.10, revenue of $10.2M beats by $0.06M |
| 2025-08-08 | +24.0% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2025-10-07 | -23.5% | earnings | Seeking Alpha | SANUWAVE Health, Inc. (SNWV) Q3 2025 Earnings Call Transcript |
| 2025-10-07 | -23.5% | earnings | Benzinga | Aehr Test Systems Posts Q1 Earnings, Joins SANUWAVE Health And Other Big Stocks Moving Lower In Tuesday's - Benzinga |
| 2025-03-21 | +19.4% | earnings | Seeking Alpha | SANUWAVE Health reports Q4 results |
| 2025-03-21 | +19.4% | earnings | Seeking Alpha | SANUWAVE Health, Inc. (SNWV) Q4 2024 Earnings Call Transcript |
| 2025-03-21 | +19.4% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2024-11-08 | +14.9% | earnings | Seeking Alpha | SANUWAVE Health reports Q3 results |
| 2024-11-08 | +14.9% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2025-10-06 | -14.5% | earnings | Seeking Alpha | Sanuwave Health expects Q3 revenue between $11.4M and $11.6M |
| 2025-08-20 | +13.1% | legal | SEC EDGAR | SNWV 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-08-21 | +12.9% | legal | SEC EDGAR | SNWV 8-K: 8.01 (SEC Filing) |
| 2025-01-10 | +12.5% | legal | SEC EDGAR | SNWV 8-K: 5.02 and 7.01 (SEC Filing) |
| 2026-04-16 | +11.4% | earnings | GlobeNewswire | Sanuwave Health Reports Preliminary Q1 2026 Revenue of $9.6–$9.7 Million, Up 3-4% Year-over-Year |
| 2026-04-16 | +11.4% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2026-04-16 | +11.4% | earnings | Stock Titan | Sanuwave (NASDAQ: SNWV) sees Q1 2026 revenue at $9.6–$9.7M - Stock Titan |
| 2026-04-16 | +11.4% | earnings | Stock Titan | Reimbursement shifts shake wound care; Sanuwave Q1 sales near $9.7M - Stock Titan |
| 2025-03-07 | -10.6% | legal | SEC EDGAR | SNWV 8-K: 5.03, 5.05, 7.01, 8.01 (SEC Filing) |
| 2025-03-07 | -10.6% | news | TradingView | SNWV Stock Price and Chart — NASDAQ:SNWV - TradingView |
| 2025-06-26 | -10.2% | legal | SEC EDGAR | SNWV 8-K: 8.01 (SEC Filing) |
| 2025-03-04 | +8.8% | news | Seeking Alpha | Sanuwave Health to uplist to the Nasdaq Global Market |
| 2025-11-08 | +8.7% | earnings | Seeking Alpha | SANUWAVE Health, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-01-15 | -8.4% | legal | SEC EDGAR | SNWV 8-K: 5.02 and (SEC Filing) |
| 2025-09-15 | -8.2% | news | Seeking Alpha | Sanuwave: A Long-Term Compounder In Its Early Stages |
| 2025-09-15 | -8.2% | news | Seeking Alpha | Sanuwave: A Long Term Compounder In Its Early Stages (NASDAQ:SNWV) - Seeking Alpha |
| 2024-10-25 | +8.0% | legal | SEC EDGAR | SNWV 8-K: 5.02 and (SEC Filing) |
| 2025-04-04 | +7.3% | news | Nasdaq | Sanuwave Health Rings the Closing Bell - Nasdaq |
| 2025-05-09 | -6.3% | earnings | Seeking Alpha | SANUWAVE Health GAAP EPS of -$0.66, revenue of $9.3M |
| 2025-05-09 | -6.3% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2025-12-11 | +6.3% | news | Investing.com | Manchester explorer sells $4.45 million in Sanuwave Health (SNWV) - Investing.com |
| 2026-03-29 | -6.2% | analyst | Simply Wall St. | How The Reset Price Target Is Rewriting The Story For SANUWAVE Health (SNWV) |
| 2026-03-29 | -6.2% | analyst | Yahoo Finance | How The Reset Price Target Is Rewriting The Story For SANUWAVE Health (SNWV) - Yahoo Finance |
| 2026-03-28 | -6.2% | earnings | Moby | SANUWAVE Health, Inc. Q4 2025 Earnings Call Summary |
| 2026-04-10 | -6.0% | news | GuruFocus | SANUWAVE Health Inc (SNWV) Shares Fall 7.2% -- GF Value Says Sti - GuruFocus |
| 2025-12-10 | +6.0% | news | simplywall.st | SANUWAVE Health, Inc. (NASDAQ:SNWV) Is About To Turn The Corner - simplywall.st |
| 2025-01-14 | -5.9% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2026-03-27 | -5.7% | earnings | MarketBeat | Sanuwave Health Q4 Earnings Call Highlights |
| 2026-03-27 | -5.7% | earnings | Seeking Alpha | SANUWAVE outlines 16–25% revenue growth target for 2026 as reseller expansion accelerates |
| 2026-03-27 | -5.7% | earnings | Seeking Alpha | SANUWAVE Health, Inc. (SNWV) Q4 2025 Earnings Call Transcript |
| 2026-03-27 | -5.7% | earnings | Seeking Alpha | SANUWAVE Health, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-03-27 | -5.7% | earnings | Seeking Alpha | SANUWAVE Health reports Q4 results; gives Q1 and FY outlook |
| 2026-03-27 | -5.7% | news | Stock Titan | Vanguard disaggregates holdings in SANUWAVE (NASDAQ: SNWV) — 0% reported - Stock Titan |
| 2026-03-27 | -5.7% | earnings | Seeking Alpha | SANUWAVE Health, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SNWV) 2026-03-27 - Seeking Alpha |
| 2025-04-08 | -5.6% | earnings | Seeking Alpha | SANUWAVE Health sees Q1 revenue between $9.1m and $9.3M |
| 2025-04-08 | -5.6% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2025-05-29 | -5.4% | legal | SEC EDGAR | SNWV 8-K: 5.02 (SEC Filing) |
| 2026-04-20 | -5.2% | news | Insider Monkey | Sanuwave Health (SNWV) Slipped as CMS Dropped the Coverage Limit |
| 2026-04-20 | -5.2% | legal | Cổng thông tin điện tử Tỉnh Sơn La | SANUWAVE Health (SNWV) Stock: Investment Signals (Smart Money Exits) 2026-04-20 - Sector Rotation - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-01-09 | -4.9% | earnings | Seeking Alpha | Sanuwave Health expects record annual revenue |
| 2026-01-09 | -4.9% | earnings | Stock Titan | Record year for advanced wound care firm as revenue jumps nearly 30% - Stock Titan |
| 2026-04-23 | -4.8% | earnings | Xã Thanh Hà | Is SANUWAVE Health (SNWV) stock in a good position today | SANUWAVE Health posts 413pct EPS beat vs estimates - Earnings Preview - Xã Thanh Hà |
| 2025-10-30 | -4.2% | legal | SEC EDGAR | SNWV 8-K: 5.02 and (SEC Filing) |
| 2025-07-14 | -4.1% | legal | SEC EDGAR | SNWV 8-K: 2.02 (SEC Filing) |
| 2025-11-03 | -4.0% | news | Stock Titan | Sanuwave (NASDAQ: SNWV): CMS finalizes UltraMIST CPT 97610 rates, 2026 largely unchanged - Stock Titan |
| 2026-02-10 | -3.3% | news | Simply Wall St. | SANUWAVE Health (NASDAQ:SNWV) investors are sitting on a loss of 63% if they invested five years ago |
| 2026-02-10 | -3.3% | news | Yahoo Finance | SANUWAVE Health (NASDAQ:SNWV) investors are sitting on a loss of 63% if they invested five years ago - Yahoo Finance |
| 2024-11-13 | +3.3% | legal | SEC EDGAR | SNWV 8-K: 5.02 and (SEC Filing) |
| 2026-03-26 | -3.2% | earnings | GlobeNewswire | Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 |
| 2026-03-26 | -3.2% | earnings | GuruFocus.com | SANUWAVE Health Inc (SNWV) Q4 2025 Earnings Report Preview: What To Look For |
| 2026-03-26 | -3.2% | legal | SEC EDGAR | SNWV 8-K: 2.02 and (SEC Filing) |
| 2026-03-26 | -3.2% | earnings | Stock Titan | Sanuwave sold 255 wound-care systems in Q4, targets up to $55M - Stock Titan |
| 2026-03-26 | -3.2% | news | Stock Titan | [8-K] SANUWAVE Health, Inc. Reports Material Event - Stock Titan |
| 2026-01-27 | -3.1% | news | Seeking Alpha | Sanuwave: A Compelling Asymmetric Opportunity In Advanced Wound Care |
| 2026-01-27 | -3.1% | news | Seeking Alpha | Sanuwave: A Compelling Asymmetric Opportunity In Advanced Wound Care - Seeking Alpha |
| 2025-10-01 | -2.9% | legal | SEC EDGAR | SNWV 8-K: 5.02 (SEC Filing) |
| 2025-07-31 | +2.7% | legal | SEC EDGAR | SNWV 8-K: 5.02 and (SEC Filing) |
| 2026-04-06 | -2.6% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is SANUWAVE Health (SNWV) Stock Moving Higher | Price at $17.50, Up 3.52% - Bearish Pattern - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-03-09 | -2.5% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-06-03 | +2.4% | legal | SEC EDGAR | SNWV 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-08-22 | +2.3% | news | Seeking Alpha | Sanuwave Health rises after $5M payment related to patent sale |
| 2026-04-21 | -2.3% | news | Stock Titan | SANUWAVE Health (SNWV) holder Opaleye logs 16,469-share stock sale - Stock Titan |
| 2025-03-31 | +2.2% | legal | SEC EDGAR | SNWV 8-K: 1.01 and (SEC Filing) |
| 2026-04-22 | -1.9% | news | Benzinga | SANUWAVE Health 10% Owner Trades $336K In Company Stock - Benzinga |
| 2025-05-10 | -1.8% | earnings | Seeking Alpha | Sanuwave health targets 40%-50% Q2 revenue growth with strategic customer focus |
| 2025-05-10 | -1.8% | earnings | Seeking Alpha | SANUWAVE Health, Inc. (SNWV) Q1 2025 Earnings Call Transcript |
| 2026-04-13 | +1.8% | analyst | Simply Wall St. | How The SANUWAVE Health (SNWV) Investment Narrative Is Resetting After A Lower Price Target |
| 2025-09-26 | -1.5% | news | Seeking Alpha | Sanuwave refinances debt with new credit facility |
| 2025-09-26 | -1.5% | legal | SEC EDGAR | SNWV 8-K: 1.01, 1.02, 2.03, 7.01 (SEC Filing) |
| 2026-03-12 | -1.1% | legal | DirectorsTalk Interviews | SANUWAVE Health, Inc. (SNWV) Stock Analysis: Exploring a Potential 142.91% Upside in the Medical Device Sector - DirectorsTalk Interviews |
| 2025-03-22 | +1.1% | news | ChartMill | SNWV Stock Price, Quote & Chart | SANUWAVE HEALTH INC (NASDAQ:SNWV) - ChartMill |
| 2025-03-22 | +1.1% | analyst | ChartMill | SNWV Forecast, Price Target & Analyst Ratings | SANUWAVE HEALTH INC (NASDAQ:SNWV) - ChartMill |
| 2026-04-02 | +1.0% | news | Stock Titan | [Form 4] SANUWAVE Health, Inc. Insider Trading Activity - Stock Titan |
| 2026-04-02 | +1.0% | executive | Stock Titan | SANUWAVE Health (SNVW) CEO Frank Morgan awarded 3,208 stock options - Stock Titan |
| 2026-04-02 | +1.0% | news | Stock Titan | Director Tyler James granted 3,208 SANUWAVE (SNWV) stock options at $17.29 - Stock Titan |
| 2026-04-02 | +1.0% | legal | Stock Titan | SNWV SEC Filings - Sanuwave Health 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2025-05-28 | +1.0% | news | Seeking Alpha | Sanuwave Health announces inclusion in Russell 2000 index |
| 2026-03-20 | +0.5% | earnings | GlobeNewswire | Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results |
| 2026-03-20 | +0.5% | news | Stock Titan | March 27 is when Sanuwave breaks down its 2025 results live - Stock Titan |
| 2026-02-05 | -0.4% | news | Yahoo Finance | Deep Sail Capital Partners’ Investment Thesis for Sanuwave Health (SNWV) - Yahoo Finance |
| 2025-06-11 | +0.4% | news | Seeking Alpha | Sanuwave: High Growth Wound Care Tech Primed For A Breakout |
| 2025-06-11 | +0.4% | news | Seeking Alpha | Sanuwave: High Growth Wound Care Tech Primed For A Breakout - Seeking Alpha |
| 2025-10-02 | -0.1% | earnings | MarketBeat | 3 Lesser-Known Healthcare Names With Major Upside in Store - MarketBeat |
| 2024-10-18 | — | news | Seeking Alpha | SANUWAVE announces 1-for-375 reverse stock split |
| 2024-10-18 | — | legal | SEC EDGAR | SNWV 8-K: 1.01, 3.02, 3.03, 5.03, 7.01 (SEC Filing) |
| 2024-10-18 | — | news | Yahoo Finance | SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering - Yahoo Finance |